blog
TSO and MS: Phase 1 Clincal Trial Complete
The Phase 1 clinical trial of TSO for treatment of Multiple Sclerosis, conducted by Dr.Fleming at the University of Wisconsin School of Medicine and Public Health, is now complete. No adverse effects in the 5 patients, and a reduction of MRI-measured brain leasions in all 5. The abstract is available here
Comments
There are currently no comments for this post